Last edition
News about "Hevaxin "
Dr Reddy's Launches Recombinant Hepatitis E Vaccine Hevaxin in India
According to Dr Reddy’s, clinical studies show that Hevaxin offers protective efficacy, durable immunity, and a favourable immune response, supported by an established safety and tolerability profile.
Hevaxin | 07/01/2026 | By News Bureau | 140
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members